SCHEMBL2046183

SCHEMBL2046183

C=CC(SC(=S)c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.37
AKT1 P31749 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP2C19 P33261 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
EPHX2 P34913 1/20 0.32
POLB P06746 2/20 0.32
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 2/20 0.31
PTGS1 P23219 2/20 0.31
CXCR1 P25024 2/20 0.31
CXCR2 P25025 2/20 0.31
PTGS2 P35354 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004825 0.81 CYP2C19 (0.33) LMNACYP2C19ALDH1A1KDM4EHSD17B10
SCHEMBL11500737 0.74 CYP2D6 (0.41) CYP2C19KMT2ARECQLMAPK1
SCHEMBL16128977 0.74 CYP2D6 (0.42) LMNATDP1L3MBTL1CYP2C19CES2
SCHEMBL2152870 0.74 ALDH1A1 (0.43) LMNAL3MBTL1CYP2C19ALDH1A1MAPT
SCHEMBL776296 0.73 CYP2C19 (0.36) LMNATDP1CYP2C19ALDH1A1MAPT
SCHEMBL776368 0.73 CYP2C19 (0.36) LMNATDP1CYP2C19ALDH1A1MAPT
SCHEMBL122869 0.71 ADRA2C (0.39) LMNATDP1L3MBTL1CYP2C19CES2
SCHEMBL7206079 0.70 LMNA (0.35) LMNATDP1CYP2C19ALDH1A1MAPT
SCHEMBL776369 0.70 CYP2C19 (0.34) LMNACYP2C19ALDH1A1MAPTKDM4E
SCHEMBL9112613 0.68 KDM4E (0.33) LMNATDP1CYP2C19ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883912-B2 Synthesis of arborescent polymers via controlled inimer-type reversible addition-fragmentation chain transfer (RAFT) polymerization UNIVERSITY OF AKRON (US) 2014-11-11 US disclosed
US-20110144268-A1 SYNTHESIS OF ARBORESCENT POLYMERS VIA CONTROLLED INIMER-TYPE REVERSIBLE ADDITION-FRAGMENTATION CHAIN TRANSFER (RAFT) POLYMERIZATION THE UNIVERSITY OF AKRON (US) 2011-06-16 US disclosed
US-7714075-B1 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-05-11 US disclosed
US-7666962-B2 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-02-23 US disclosed
WO-2010019563-A1 SYNTHESIS OF ARBORESCENT POLYMERS VIA CONTROLLED INIMER-TYPE REVERSIBLE ADDITION-FRAGMENTATION CHAIN TRANSFER (RAFT) POLYMERIZATION THE UNIVERSITY OF AKRON (US) 2010-02-18 WO disclosed
US-7662986-B2 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-02-16 US disclosed
US-20080139836-A1 Polymerization with living characteristics LE TAM PHUONG 2008-06-12 US disclosed
US-20080139764-A1 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2008-06-12 US disclosed
US-7250479-B2 Polymerization with living characteristics E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-07-31 US disclosed
US-20040171777-A1 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-09-02 US disclosed
EP-0910587-B1 POLYMERIZATION WITH LIVING CHARACTERISTICS DU PONT (US) 2001-12-12 EP disclosed
EP-0910587-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-04-28 EP disclosed
WO-1998001478-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139836-A1 Polymerization with living characteristics UQCRB, MTR, UQCRC2 LMNA 3210/4885AKT1 4304/4885TDP1 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.